Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (41-50 of 310) with videos related to

Pageof 31
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 20, 2024
Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive declineIsmael L Calandri, Carolina A Ardohain, Sofia A Elgani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2019
Predicting diagnosis and cognition with <sup>18</sup>F-AV-1451 tau PET and structural MRI in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Michael Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's diseaseEllen Hanna Singleton, Niklas Mattsson-Carlgren, Alexa Pichet Binette, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2021
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkKonstantinos Chiotis, Alessandra Dodich, Marina Boccardi, et al.
Alzheimer'S Research & Therapy|September 24, 2022
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's diseaseAnna Rubinski, Nicolai Franzmeier, Anna Dewenter, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort studyIsabelle Glans, Niklas Mattsson-Carlgren, Olof Strandberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2022
Alzheimer Disease: Standard of Diagnosis, Treatment, Care, and PreventionStefan Teipel, Deborah Gustafson, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumBastiaan G J van Tol, Colin Groot, Elsmarieke van de Giessen, et al.
Alzheimer'S Research & Therapy|July 25, 2022
Issues and recommendations for the residual approach to quantifying cognitive resilience and reserveJeremy A Elman, Jacob W Vogel, Diana I Bocancea, et al.
Brain : a Journal of Neurology|January 13, 2021
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjectsRuben Smith, Olof Strandberg, Niklas Mattsson-Carlgren, et al.
Pageof 31

Showing results (41-50 of 310) with videos related to

Sort By:
Pageof 31
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 20, 2024
Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive declineIsmael L Calandri, Carolina A Ardohain, Sofia A Elgani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2019
Predicting diagnosis and cognition with <sup>18</sup>F-AV-1451 tau PET and structural MRI in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Michael Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's diseaseEllen Hanna Singleton, Niklas Mattsson-Carlgren, Alexa Pichet Binette, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2021
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkKonstantinos Chiotis, Alessandra Dodich, Marina Boccardi, et al.
Alzheimer'S Research & Therapy|September 24, 2022
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's diseaseAnna Rubinski, Nicolai Franzmeier, Anna Dewenter, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort studyIsabelle Glans, Niklas Mattsson-Carlgren, Olof Strandberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2022
Alzheimer Disease: Standard of Diagnosis, Treatment, Care, and PreventionStefan Teipel, Deborah Gustafson, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumBastiaan G J van Tol, Colin Groot, Elsmarieke van de Giessen, et al.
Alzheimer'S Research & Therapy|July 25, 2022
Issues and recommendations for the residual approach to quantifying cognitive resilience and reserveJeremy A Elman, Jacob W Vogel, Diana I Bocancea, et al.
Brain : a Journal of Neurology|January 13, 2021
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjectsRuben Smith, Olof Strandberg, Niklas Mattsson-Carlgren, et al.
Pageof 31